Johnson & Johnson on Wednesday lowered its previously reported profit for the third quarter to US$1.8 billion from US$4.8 billion to account for a proposed opioid settlement payment.
Johnson & Johnson says proposed opioid settlement to lower reported third-quarter profit by US$3 billion
